Close Menu

research alliance

The software tool, currently in development, is set to be introduced next year and could also find application in other indications such as cancer.

RenalytixAI's flagship product is KidneyIntelX, which applies artificial intelligence to patient data to aid in the treatment of progressive kidney disease.

The effort aims to screen for SARS-CoV-2 in the San Diego community and study the virus' genome to better understand how it is transmitted.

The researchers presented their findings during the European Society of Human Genetics meeting, which was webcast this week.

The company and the Harvard TH Chan School of Public Health will study the use of microbial biomarkers to identify precancerous adenomas and carcinomas in the colon.

Seven Bridges will help build a computational infrastructure to harmonize data from Zero Childhood Cancer with datasets from other research projects.

Backed by BARDA, Merck and Institute for Systems Biology are studying multiomic data to understand infection pathways and find biomarkers for symptom risk.

The Cold Spring Harbor Laboratory spinout will build predictive models for lung cancer progression and risk using its SpliceCore software platform.

As part of the deal, Applied DNA will permanently place robotic and diagnostic equipment at the hospital to enable validation of the test.

This new partnership between Harvard's Chan School of Public Health and the Human Vaccines Project seeks to apply AI and genomics to accelerate vaccine development.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.